Effect of anticoagulant therapy on cell-derived microparticles and pregnancy outcome in women with pregnancy loss

British Journal of Haematology

Volumn 171, Issue 5, 2015, Pages 892-896

  Patil, Rucha ^a   Ghosh, Kanjaksha ^a   Damania, Kaizad ^b   Bansal, Vandana ^b   Satoskar, Purnima ^b   Darekar, Anjali ^b   Shetty, Shrimati ^a  

^a KEM HOSPITAL   (India)

^b Nowrosjee Wadia Maternity Hospital   (India)

Author keywords

Anticoagulant therapy; Cell derived microparticles; Heparin; Recurrent pregnancy loss; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PHOSPHATIDYLSERINE;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FETUS DEATH; GESTATIONAL AGE; HUMAN; HUMAN CELL; LIVE BIRTH; MEMBRANE MICROPARTICLE; PATIENT MONITORING; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; SPONTANEOUS ABORTION; THROMBOPHILIA; ABORTION, HABITUAL; CASE CONTROL STUDY; METABOLISM; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; YOUNG ADULT;

ABORTION, HABITUAL; ADULT; ANTICOAGULANTS; ASPIRIN; CASE-CONTROL STUDIES; CELL-DERIVED MICROPARTICLES; FEMALE; HEPARIN; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; THROMBOPHILIA; YOUNG ADULT;

EID: 84955392595     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.13460     Document Type: Article

References (10)

1. Bulut, D., Becker, V. & Mügge, A. (2011) Acetylsalicylate reduces endothelial and platelet-derived microparticles in patients with coronary artery disease. Canadian Journal of Physiology and Pharmacology, 89, 239-244.
2. Carp, H., Dardik, R., Lubetsky, A., Salomon, O., Eskaraev, R., Rosenthal, E. & Inbal, A. (2004) Prevalence of circulating procoagulant microparticles in women with recurrent miscarriage: a case-controlled study. Human Reproduction, 19, 191-195.
3. Girardi, G. (2005) Heparin treatment in pregnancy loss: potential therapeutic benefits beyond anticoagulation. Journal of Reproductive Immunology, 66, 45-51.
4. Jy, W., Horstman, L.L. & Ahn, Y.S. (2010) Microparticle size and its relation to composition, functional activity, and clinical significance. Seminars in Thrombosis and Hemostasis, 36, 876-880.
5. Laude, I., Rongières-Bertrand, C., Boyer-Neumann, C., Wolf, M., Mairovitz, V., Hugel, B., Freyssinet, J.M., Frydman, R., Meyer, D. & Eschwège, V. (2001) Circulating procoagulant microparticles in women with unexplained pregnancy loss: a new insight. Thrombosis and Haemostasis, 85, 18-21.
6. Mitić, G., Novakov Mikić, A., Povazan, L., Mitreski, A., Kopitović, V. & Vejnović, T. (2011) Thromboprophylaxis implementation during pregnancy in women with recurrent foetal losses and thrombophilia. Medicinski Pregled, 64, 471-475.
7. Patil, R., Ghosh, K., Satoskar, P. & Shetty, S. (2013) Elevated procoagulant endothelial and tissue factor expressing microparticles in women with recurrent pregnancy loss. PLoS ONE, 20, e81407.
8. Rai, R. (2003) Is miscarriage a coagulopathy? Current Opinion in Obstetrics and Gynecology, 15, 265-268.
9. Rai, R., Backos, M., Baxter, N., Chilcott, I. & Regan, L. (2000) Recurrent miscarriage - an aspirin a day? Human Reproduction, 15, 2220-2223.
10. Rodger, M.A., Hague, W.M., Kingdom, J., Kahn, S.R., Karovitch, A., Sermer, M., Clement, A.M., Coat, S., Chan, W.S., Said, J., Rey, E., Robinson, S., Khurana, R., Demers, C., Kovacs, M.J., Solymoss, S., Hinshaw, K., Dwyer, J., Smith, G., McDonald, S., Newstead-Angel, J., McLeod, A., Khandelwal, M., Silver, R.M., Le Gal, G., Greer, I.A., Keely, E., Rosene-Montella, K., Walker, M. & Wells, P.S.; TIPPS Investigators. (2014) Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial. Lancet, 384, 1673-1683.